FindMyKOL
Clinical trialNCT05595499RecruitingPhase 2Interventional

Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors

SponsorJonsson Comprehensive Cancer CenterEnrollment88Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This phase II trial tests whether fisetin works to improve physical function in women who have received chemotherapy for stage I-III breast cancer treatment. Fisetin is a naturally occurring substance that is found in strawberries and other foods. Fisetin eliminates cells that have undergone a process called senescence. Senescence is when a cell ages and permanently stops dividing but does not die. Over time, large numbers of these cells build up in tissues throughout the body and can release harmful substances that causes inflammation and damages nearby healthy cells. Studies have shown that chemotherapy causes a build-up of these senescent cells. Giving fisetin may eliminate senescent cells and improve physical function in postmenopausal women who have received chemotherapy for breast cancer.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Ucla Health Cancer Care in Alhambra

    Alhambra, California, United States

    Recruiting
  • Ucla Health Beverly Hills Primary & Specialty Care

    Beverly Hills, California, United States

    Recruiting
  • Ucla Health Burbank Primary & Specialty Care

    Burbank, California, United States

    Recruiting
  • City of Hope Comprehensive Cancer Center

    Duarte, California, United States

    Lisa D. Yee, MD
    Recruiting
  • Ucla / Jonsson Comprehensive Cancer Center

    Los Angeles, California, United States

    Mina S. Sedrak
    Recruiting
  • Ucla Health Primary Care in Marina del Rey

    Marina del Rey, California, United States

    Recruiting
  • Ucla Health Primary Care in Pasadena

    Pasadena, California, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

FisetinPlacebo Administration
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
27 Mar 2023
Primary completion
14 Aug 2027
Completion
14 Aug 2028
Last update posted
17 Jul 2026
Registered enrollment
88
Registry id
NCT05595499

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.